| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Jul―09 |
Identification of FDA-Approved Drugs That Inhibit SARS-CoV-2 and Human Norovirus Replication |
Tsuyoshi Hayashi, Junki Hirano, Kosuke Murakami, Yoshiki Fujii, Sakura Kobayashi, Takashi Tanikawa, Masashi Kitamura, Yuichi Someya |
| 2 |
[GO] |
2025―May―16 |
Treatment of Long Coronavirus Disease in Japan: A Nationwide Study of Symptom-Associated Drug Prescriptions |
Yuka Kogure, Wataru Ando, Kyoka Sakamaki, Mitsuhiro Sugawara |
| 3 |
[GO] |
2025―Apr―23 |
Evaluation of the Influence of the National Action Plan on Antimicrobial Resistance and the COVID-19 Pandemic on the Consumption of Broad-Spectrum Antimicrobial and Anti-methicillin-resistant <i>Staphylococcus aureus</i> Agents |
Ryota Goto, Ryo Inose, Ryuji Koizumi, Keisuke Sawada, Masahiro Ishikane, Norio Ohmagari, Yuichi Muraki |
| 4 |
[GO] |
2024―Nov―07 |
Sunflower Trypsin Monocyclic Inhibitor Selected for the Main Protease of SARS-CoV-2 by Phage Display |
Graziele Cristina Ferreira, Verônica de Moraes Manzato, Debora Noma Okamoto, Livia Rosa Fernandes, Deivid Martins Santos, Gabriel Cerqueira Alves Costa, Fernando Allan Abreu Silva, Ricardo Jose Soares Torquato, Giuseppe Palmisano, Maria Aparecida Juliano, Aparecida Sadae Tanaka |
| 5 |
[GO] |
2024―May―16 |
Computational Estimation of Residues Involving Resistance to the SARS-CoV-2 Main Protease Inhibitor Ensitrelvir Based on Virtual Alanine Scan of the Active Site |
Ayato Mizuno, Tomoki Nakayoshi, Koichi Kato, Eiji Kurimoto, Akifumi Oda |
| 6 |
[GO] |
2024―May―16 |
Ciclesonide Inhibits SARS-CoV-2 Papain-Like Protease <i>in Vitro</i> |
Yuka Kiba, Takashi Tanikawa, Masashi Kitamura |
| 7 |
[GO] |
2024―Apr―30 |
Current Status and Perspectives of Therapeutic Antibodies Targeting the Spike Protein S2 Subunit against SARS-CoV-2 |
Yuichiro Yamamoto, Tetsuya Inoue |
| 8 |
[GO] |
2024―Apr―30 |
Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yne |
Mana Murae, Shota Sakai, Non Miyata, Yoshimi Shimizu, Yuko Okemoto-Nakamura, Takuma Kishimoto, Motohiko Ogawa, Hideki Tani, Kazuma Tanaka, Kohji Noguchi, Masayoshi Fukasawa |
| 9 |
[GO] |
2023―Oct―20 |
Removal of soluble ACE2 in VeroE6 cells by 17β-estradiol reduces SARS-CoV-2 infectivity |
Yuta Kyosei, Teruki Yoshimura, Etsuro Ito |
| 10 |
[GO] |
2022―Oct―07 |
Safety of remdesivir in 20 children with COVID-19 -case series- |
Shuji Manabe, Shinsuke Mizuno, Tsuyoshi Jinda, Masashi Kasai |
| 11 |
[GO] |
2022―Sep―30 |
Dihydroceramide Δ4-Desaturase 1 Is Not Involved in SARS-CoV-2 Infection |
Yasuhiro Hayashi, Kouki Matsuda, Kazunari Tanigawa, Takashi Tanikawa, Kenji Maeda, Kiyoto Tsuchiya |
| 12 |
[GO] |
2022―Jun―30 |
Evaluation of a Webinar for Pharmacists Learning Basic Clinical-Oncology during COVID-19 Pandemic in Japan |
Hideyuki Terazono, Masami Tsuchiya, Yosuke Maki, Naoki Yoshikawa, Yosuke Kawahara, Keiko Nishimura, Keisuke Shinohara, Daisuke Ogawa, Riho Mori, Yoshihiro Iwamoto, Fumio Itagaki, Hiroyuki Masuko, Masahito Yonemura, Mayako Uchida |
| 13 |
[GO] |
2022―Jan―21 |
Simultaneous Screening of SARS-CoV-2 Omicron and Delta Variants Using High-Resolution Melting Analysis |
Akira Aoki, Yoko Mori, Yoshinori Okamoto, Hideto Jinno |
| 14 |
[GO] |
2021―Jun―30 |
Remote Reminiscence Using Immersive Virtual Reality May Be Efficacious for Reducing Anxiety in Patients with Mild Cognitive Impairment Even in COVID-19 Pandemic: A Case Report |
Megumi Yahara, Kazuyuki Niki, Keita Ueno, Mio Okamoto, Takeshi Okuda, Hiroyuki Tanaka, Yasuo Naito, Ryouhei Ishii, Mikiko Ueda, Toshinori Ito |
| 15 |
[GO] |
2021―Jun―18 |
Improved detection sensitivity of an antigen test for SARS-CoV-2 nucleocapsid proteins with thio-NAD cycling |
Yuta Kyosei, Mayuri Namba, Sou Yamura, Satoshi Watabe, Teruki Yoshimura, Tadahiro Sasaki, Tatsuo Shioda, Etsuro Ito |
|
